Looks like we will stay between $1.20 and $1.60 till we get some more news!
1. FDA strategy for approval via consultants
2. Any potential licensing/partnerships in key markets (US, Europe, Asia)
3. The launch of our Direct to Consumer teleclinic.
We’ve held up well compared to the entire pharmaceutical/bio space since RFK announcement.
Looks like we will stay between $1.20 and $1.60 till we get some...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.005(1.75%) |
Mkt cap ! $31.90M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 29.5¢ | 28.0¢ | $106.6K | 374.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 45487 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 39992 | 3 |
View Market Depth
| Last trade - 14.20pm 18/06/2025 (20 minute delay) ? |
| LTP (ASX) Chart |